Skip to main content

Albemarle Corporation guidance

  • ALB · NYSE
  • Chemicals
  • Specialty Chemicals
  • S&P 500
$88.16−5.74%Close 16 Nov 2026 · Market value $10.45B

Albemarle Corporation gives no forecast in figures in its latest earnings release (4 Nov 2026). Many companies give their outlook on the call only, or none at all.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Guidance against results above 0 · within 1 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
Capital expendituresFY2026About $500MRaised once—To come
Capital expenditures growthFY2026−15%Given once—To come
Capital expendituresFY2025About $600MLowered 3 times$590MWithin the range

ALB in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.